Literature DB >> 25560596

Evaluation of colorectal cancers for Lynch syndrome: practical molecular diagnostics for surgical pathologists.

Wade S Samowitz1.   

Abstract

Lynch syndrome is the most common inherited colorectal cancer syndrome, accounting for 2-4% of all colorectal cancer cases. This review focuses on the tissue workup of Lynch syndrome, including methods to determine whether or not a tumor is mismatch repair deficient, and whether a mismatch repair-deficient tumor is sporadic or Lynch syndrome-associated. Strategies for determining which tumors to test and how best to implement a Lynch syndrome screening program are also discussed, as well as potential developments in the future.

Entities:  

Mesh:

Year:  2015        PMID: 25560596     DOI: 10.1038/modpathol.2014.127

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?

Authors:  Yang Wang; Chanjuan Shi; Rosana Eisenberg; Cindy L Vnencak-Jones
Journal:  J Mol Diagn       Date:  2016-11-01       Impact factor: 5.568

Review 2.  Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.

Authors:  Larissa V Furtado; Wade S Samowitz
Journal:  Virchows Arch       Date:  2017-05-27       Impact factor: 4.064

3.  Microsatellite instability in endometrial cancer: New purpose for an old test.

Authors:  Katherine C Kurnit; Shannon N Westin; Robert L Coleman
Journal:  Cancer       Date:  2019-03-26       Impact factor: 6.860

4.  Less correlation between mismatch repair proteins deficiency and decreased expression of HLA class I molecules in endometrial carcinoma: a different propensity from colorectal cancer.

Authors:  Tasuku Mariya; Terufumi Kubo; Yoshihiko Hirohashi; Junko Yanagawa; Yuta Tabuchi; Kazuhiko Matsuo; Kiyoshi Furumura; Rena Morita; Munehide Nakatsugawa; Takayuki Kanaseki; Tomohide Tsukahara; Tadashi Hasegawa; Tsuyoshi Saito; Toshihiko Torigoe
Journal:  Med Mol Morphol       Date:  2020-05-14       Impact factor: 2.309

5.  Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.

Authors:  Monika Vyas; Canan Firat; Jaclyn F Hechtman; Martin R Weiser; Rona Yaeger; Chad Vanderbilt; Jamal K Benhamida; Ajaratu Keshinro; Liying Zhang; Peter Ntiamoah; Marco Gonzalez; Rebecca Andrade; Imane El Dika; Arnold J Markowitz; J Joshua Smith; Julio Garcia-Aguilar; Efsevia Vakiani; David S Klimstra; Zsofia K Stadler; Jinru Shia
Journal:  Fam Cancer       Date:  2020-10-09       Impact factor: 2.446

Review 6.  Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers.

Authors:  Liisa Chang; Minna Chang; Hanna M Chang; Fuju Chang
Journal:  J Gastrointest Cancer       Date:  2017-12

7.  Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.

Authors:  Euno Choi; Mee Soo Chang; Sun-Ju Byeon; Heejin Jin; Kyeong Cheon Jung; Haeryoung Kim; Kook Lae Lee; Won Kim; Jin Hyun Park; Ki Hwan Kim; Jin-Soo Kim; In Sil Choi; Dong-Seok Han; Hye Seong Ahn; Seung Chul Heo
Journal:  Diagn Pathol       Date:  2020-06-04       Impact factor: 2.644

Review 8.  Correlations between microsatellite instability and the biological behaviour of tumours.

Authors:  Guang Yang; Ru-Yi Zheng; Zai-Shun Jin
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

9.  CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer.

Authors:  Xuehui Wu; Xiaoliang Lan; Wanming Hu; Wanning Zhang; Xiangmeng Lai; Shaowan Xu; Jiaoying Li; Weihao Qiu; Wei Wang; Jianbiao Xiao; Feifei Wang; Yanqing Ding; Li Liang
Journal:  Cancer Immunol Immunother       Date:  2021-04-05       Impact factor: 6.968

Review 10.  Fundamental and Essential Knowledge for Pathologists Engaged in the Research and Practice of Immune Checkpoint Inhibitor-Based Cancer Immunotherapy.

Authors:  Terufumi Kubo; Tomoyo Shinkawa; Yasuhiro Kikuchi; Kenji Murata; Takayuki Kanaseki; Tomohide Tsukahara; Yoshihiko Hirohashi; Toshihiko Torigoe
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.